Its effect was associated with primarily grade 1–2 adverse events, including hypertension, increased ALT (alanine transaminase), asthenia, nausea, diarrhea, thrombocytopenia, neutropenia, and anemia [79]. This evidence concerns the gene GPT and neutropenia.